52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Zimmer Biomet Reports Q1 EPS $0.94
Zimmer Biomet Announces Changes To Company's Board Of Directors
Zimmer Biomet Announces Intent To Spin Off Spine And Dental Businesses
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Medical Equipment & Supplies
345 E Main St
Bryan C. Hanson
Chairman of the Board, President, Chief Executive Officer
Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President
Wilfred Van Zuilen
President - Europe, Middle East and Africa
President, Asia Pacific
Chief Operating Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
* SETS QUARTERLY CASH DIVIDEND OF $0.24PER SHARE Source text for Eikon: Further company coverage:
* CONFORMIS - ZIMMER IS REQUIRED TO PAY CONFORMIS $3.5 MILLION WITHIN 30 DAYS
* ZIMMER BIOMET ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS
* ZIMMER BIOMET HOLDINGS INC - ON APRIL 23 ENTERED INTO A REVOLVING CREDIT AGREEMENT
* ZIMMER BIOMET HOLDINGS INC - WITHDRAWING FULL-YEAR FINANCIAL GUIDANCE IT PREVIOUSLY ISSUED ON FEBRUARY 4, 2020
The full 3rd U.S. Circuit Court of Appeals on Tuesday let stand a panel decision that revived a Pennsylvania woman’s claims that her Zimmer Biomet hip implant was defectively designed.
A divided federal appeals court on Wednesday revived a Pennsylvania woman’s design-defect lawsuit over a Zimmer Biomet hip implant, vacating a lower-court judge’s ruling that the complaint was filed too late.
A federal appeals court on Monday upheld a $254 million patent infringement verdict Stryker Corp won against rival medical device maker Zimmer Biomet Holdings Inc, bringing a likely end to a long-running court battle that previously ended up before the U.S. Supreme Court.
Medical device maker Zimmer Biomet must face a lawsuit accusing it of denying overtime pay to sales representatives across the country by misclassifying them as independent contractors, a federal judge in San Francisco ruled.
Up to 10,000 Americans due to have hip or knee replacements will be able to funnel basic health data directly from their Apple Watches to their surgeons under a new app being tested by orthopedics company Zimmer Biomet.
Up to 10,000 Americans due to have hip or knee replacements will be able to funnel basic health data directly from their Apple Watches to their surgeons under a new app being tested by prosthetic limb specialist Zimmer Biomet .
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.